Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hamilton Robotics Builds Affymetrix’ CytoScan Automated Target Preparation Solution on Microlab NIMBUS

Published: Tuesday, January 22, 2013
Last Updated: Tuesday, January 22, 2013
Bookmark and Share
Customized Microlab NIMBUS 96 workstation helps speed clinical research with Affymetrix’ CytoScan Cytogenetics Solution.

Hamilton Robotics has announced that the soon-to-launch CytoScan Automated Target Preparation Solution from Affymetrix, Inc. is built on the customizable Microlab® NIMBUS 96 workstation from Hamilton Robotics. The Affymetrix NIMBUS Target Preparation Instrument automates target preparation for the CytoScan Cytogenetics Solution, which offers the broadest coverage and highest performance for detecting human chromosomal aberrations.

"Affymetrix chose to custom-design the NIMBUS workstation to automate sample preparation for its CytoScan Assay because the NIMBUS is a superior product at an affordable price compared to other liquid handling robots on the market. The exciting new system increases sample throughput at least two-fold for laboratories offering the CytoScan Solution for cytogenetic research applications while maintaining the same high performance," says Tanya Petrossian, Ph.D. Global Strategic Product Manager at Affymetrix.

"As an OEM partner, Hamilton Robotics was outstanding," continued Petrossian. "They worked side by side with us onsite during the early product development stage to ensure that the workstation was optimized to fit the requirements of the CytoScan Cytogenetics Solution workflow."

The Microlab NIMBUS96 is a customizable instrument platform that offers speed, ease of use, and superior pipetting performance in a small footprint for budget-conscious laboratories. The flexible system combines incredibly accurate liquid measurement with software that provides unprecedented workflow control, file handling, and integration with third-party devices. The compact, affordable system allows laboratories to process up to 96 samples at a time.
 
"Hamilton Robotics is thrilled to partner with Affymetrix to address the challenging requirements of cytogenetic researchers. Our workstations are easily adapted to even the most complex sample preparation needs of both the research environment and the rigid demands of regulated environments,” says Scott Eaton, Director of OEM and International Sales at Hamilton Robotics.

Hamilton Robotics tailor-made the Affymetrix NIMBUS for the CytoScan Assay using its rigorous custom-build process, which includes system definition, final design and system assembly, factory acceptance testing, and site acceptance testing.

“A custom-built Hamilton NIMBUS workstation offers superior quality for the same or lower price as other products on the market," says Jose Carle, Vice President at Hamilton Robotics. "Our experienced design teams, including application specialists, work closely with customers to ensure the final product perfectly matches the particular needs of the process."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hamilton Robotics and French Police Scientifique Publish Paper Describing Large-Scale Production of Genetic Profiles
More than 300,000 profiles have already been processed on the Hamilton platforms and stored in French Database.
Wednesday, March 10, 2010
Automation of Adherent Cell Culture Maintenance
Hamilton, Life & Brain and University of Bonn will jointly develop a system for the automated culture of primary cells, cell lines and embryonic stem cells.
Monday, May 14, 2007
Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Penn State, TB Alliance, and GSK Partner To Discover New Treatments For TB
A new collaboration between TB Alliance, GSK, and scientists in the Eberly College of Science seeks to find new small molecules that can be used to create antibiotics in the fight against tuberculosis (TB).
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!